Philippines approves emergency use of Pfizer’s COVID-19 drug Paxlovid

MANILA: The Philippines has approved the emergency use of Paxlovid, Pfizer’s COVID-19 drug, the country’s food and drug agency said on Friday.

It is the third COVID-19 drug approved by the agency for emergency use, after Roche’s antibody cocktail and Merck & Co Inc’s treatment pill.

Pfizer begins COVID pill study in high-risk children aged 6-17

Paxlovid can be used to treat adult patients who do not require supplemental oxygen and who are at increased risk for severe infection, the agency said.